Boehringer Ingelheim Prescription Medicines Advertiser Profile
Boehringer Ingelheim Prescription Medicines is part of:
Boehringer Ingelheim Prescription Medicines is part of C.H. Boehringer Sohn AG & Co KG. They spent under $100 million on advertising in digital, print, and national TV in the last year. They invest in premium ad units and advertised on over 100 different Media Properties in the last year across multiple Media formats. Boehringer Ingelheim Prescription Medicines launched and advertised 1 new product in the past twelve months.
We have 8 people on file in marketing roles at Boehringer Ingelheim Prescription Medicines, and 1 at their agency.
We have 8 people on file in marketing roles at Boehringer Ingelheim Prescription Medicines, and 1 at their agency.
Summary
Boehringer Ingelheim Prescription Medicines is part of C.H. Boehringer Sohn AG & Co KG. They spent under $100 million on advertising in digital, print, and national TV in the last year. They invest in premium ad units and advertised on over 100 different Media Properties in the last year across multiple Media formats. Boehringer Ingelheim Prescription Medicines launched and advertised 1 new product in the past twelve months.
We have 8 people on file in marketing roles at Boehringer Ingelheim Prescription Medicines, and 1 at their agency.
We have 8 people on file in marketing roles at Boehringer Ingelheim Prescription Medicines, and 1 at their agency.
MediaRadar helps advertising sales teams reach the key decision makers at brands. Our contacts database includes full names, email addresses, specialties, agency relationships and phone numbers, and we verify each contact every 90 days to ensure you have the most current information.
We have identified 9 decision makers for you to contact at Boehringer Ingelheim Prescription Medicines, including Executives, Strategists, Media Buyers and Agency contacts.
Dan G.
Vice President, US Cardio-Renal-Metabolic Franchise Asset & Marketing Lead
Jessica B.
Senior Associate, Integrated Media Planning (Strategy) - Boehringer Ingelheim
Michael L.
Director, Digital Health
Key Contacts
MediaRadar helps advertising sales teams reach the key decision makers at brands. Our contacts database includes full names, email addresses, specialties, agency relationships and phone numbers, and we verify each contact every 90 days to ensure you have the most current information.
We have identified 9 decision makers for you to contact at Boehringer Ingelheim Prescription Medicines, including Executives, Strategists, Media Buyers and Agency contacts.
Dan G.
Vice President, US Cardio-Renal-Metabolic Franchise Asset & Marketing Lead
Jessica B.
Senior Associate, Integrated Media Planning (Strategy) - Boehringer Ingelheim
Michael L.
Director, Digital Health
MediaRadar captures creative run on the top websites, magazines and national television stations for over 3 million brands. Here are 3 recent advertisements placed by Boehringer Ingelheim Prescription Medicines and its subsidiaries.
Display
Last ran on NEJM Journal Watch on 6/1/2024.
TV
Last ran on History on 7/20/2024.
Print
Last ran on The American Journal of Managed Care in the 05/2024 issue.
Display
Last ran on NEJM Journal Watch on 6/1/2024.
TV
Last ran on History on 7/20/2024.
Print
Last ran on The American Journal of Managed Care in the 05/2024 issue.
Recent Ad Creative
MediaRadar captures creative run on the top websites, magazines and national television stations for over 3 million brands. Here are 3 recent advertisements placed by Boehringer Ingelheim Prescription Medicines and its subsidiaries.
Display
Last ran on NEJM Journal Watch on 6/1/2024.
TV
Last ran on History on 7/20/2024.
Print
Last ran on The American Journal of Managed Care in the 05/2024 issue.
Display
Last ran on NEJM Journal Watch on 6/1/2024.
TV
Last ran on History on 7/20/2024.
Print
Last ran on The American Journal of Managed Care in the 05/2024 issue.
MediaRadar calculates estimated spend for the digital, print and national television campaigns that we identify using proprietary algorithms based on medium and advertisement type.
Boehringer Ingelheim Prescription Medicines Advertising Spend:
OVER $100 Million
Increased Spending YoY
- Boehringer Ingelheim Prescription Medicines recently bought a Spread print ad. See which other premium units they bought.
- Boehringer Ingelheim Prescription Medicines recently placed a direct ad on www.uspharmacist.com. See where else they recently placed direct ads.
- Boehringer Ingelheim Prescription Medicines recently placed a programmatic ad on www.youtube.com/. In the last 12 months, they have partnered with DoubleClick and 6 other providers. Which providers do they use most?
Media Spend
MediaRadar calculates estimated spend for the digital, print and national television campaigns that we identify using proprietary algorithms based on medium and advertisement type.
Boehringer Ingelheim Prescription Medicines Advertising Spend:
OVER $100 Million
Increased Spending YoY
- Boehringer Ingelheim Prescription Medicines recently bought a Spread print ad. See which other premium units they bought.
- Boehringer Ingelheim Prescription Medicines recently placed a direct ad on www.uspharmacist.com. See where else they recently placed direct ads.
- Boehringer Ingelheim Prescription Medicines recently placed a programmatic ad on www.youtube.com/. In the last 12 months, they have partnered with DoubleClick and 6 other providers. Which providers do they use most?
MediaRadar tracks new product launches across the 3 million+ brands in our database, and classifies each campaign to a specific product line using our proprietary classification methodology, giving you a deeper understanding of how a brand is allocating its advertising budgets. In the last year, we identified 25,873 new product launches overall.
Boehringer Ingelheim Prescription Medicines launched a campaign supporting 1 new product line in the last twelve months, SGLT2.
New Product Launches
MediaRadar tracks new product launches across the 3 million+ brands in our database, and classifies each campaign to a specific product line using our proprietary classification methodology, giving you a deeper understanding of how a brand is allocating its advertising budgets. In the last year, we identified 25,873 new product launches overall.
Boehringer Ingelheim Prescription Medicines launched a campaign supporting 1 new product line in the last twelve months, SGLT2.